ReviewReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2026
Cancer risk associated with CT imaging: quantifying the evidence, addressing misconceptions, and optimizing risk communication.
Review in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computed tomography (CT) is a cornerstone of modern diagnostics, but its increasing use has raised concerns about long-term cancer risks associated with ionizing radiation exposure. This narrative review evaluates the magnitude of cancer risk linked to CT imaging, identifies vulnerable populations, clarifies common misconceptions about radiation dose, and explores emerging strategies for risk reduction and patient-centered communication. Evidence from epidemiologic cohort studies, radiobiological models, technological assessments, and public health guidelines published over the past two decades is synthesized. The cancer risk associated with CT is small but quantifiable, particularly in pediatric and high-utilization populations. Recent advancements in CT technology have enabled substantial dose reductions, including photon-counting detector systems and AI-driven dose optimization tools that improve diagnostic quality while lowering exposure. Contemporary meta-analyses (2018-2024) also provide clearer dose-response estimates for low-dose medical radiation. Advances in imaging technology and protocol optimization have significantly reduced per-scan radiation doses; however, physician awareness and patient education remain inconsistent. Looking forward, precision imaging strategies, cumulative radiation tracking, and ultra-low-dose CT platforms represent promising future directions for minimizing risk. Minimizing harm while preserving diagnostic benefit requires evidence-based utilization, personalized imaging protocols, and transparent communication of risk, especially among high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.